 | Elsa PenneseU.O.S.D. Centro Diagnosi e Terapia dei Linfomi, Dipartimento Oncologico-Ematologico, Presidio Ospedaliero "Spirito Santo", Pescara | Lymphoma Unit, Department of Hematology, ... |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
Elsa Pennese:Expert Impact
Concepts for whichElsa Pennesehas direct influence:Platelet activation,Vivo formation,Geriatric assessment,Targeted drugs,Diabetes mellitus,Patients cll,Diffuse large,Patients dlbcl.
Elsa Pennese:KOL impact
Concepts related to the work of other authors for whichfor which Elsa Pennese has influence:Oxidative stress,Lipid peroxidation,Diabetes mellitus,Platelet activation,Type 2,Diabetic patients,Cardiovascular disease.
KOL Resume for Elsa Pennese
| Year | |
|---|---|
| 2022 | U.O.S.D. Centro Diagnosi e Terapia dei Linfomi, Dipartimento Oncologico-Ematologico, Presidio Ospedaliero "Spirito Santo", Pescara |
| 2021 | Lymphoma Unit, Department of Hematology, Ospedale Spirito Santo, Pescara, Italy. |
| 2019 | Lymphoma Unit, Department of Hematology, Ospedale Spirito Santo, Pescara, Italy |
| 1999 | From the Departments of Medicine and Aging (G.D., A.C., A.M., S.S., E.P., E.V., F. Costantini, F. Capani, C.P.) and Biomedical Sciences (T.B.), University of Chieti “G. D’Annunzio” School of Medicine; the Division of Internal Medicine, Civil Hospital of Popoli (A.F.); and the Department of Pharmacology (G.C.), Catholic University School of Medicine; Rome, Italy. |
| Concept | World rank |
|---|---|
| urinary 8isopgf2alpha excretion | #31 |
| thromboxane txm | #34 |
| txm excretion | #66 |
| urinary 8isopgf2alpha | #69 |
| pgf2alpha excretion | #82 |
| urinary txm | #83 |
| arachidonic acid peroxidation | #88 |
Prominent publications by Elsa Pennese
In Vivo Formation of 8-Iso-Prostaglandin F2α and Platelet Activation in Diabetes Mellitus
[ PUBLICATION ]
BACKGROUND: Diabetes mellitus (DM) is associated with enhanced lipid peroxidation and persistent platelet activation. We tested the hypothesis that the in vivo formation of the F2-isoprostane 8-iso-prostaglandin (PG)F2alpha, a bioactive product of arachidonic acid peroxidation, is enhanced in DM and contributes to platelet activation.
METHODS AND RESULTS: Urine samples were obtained from 85 diabetic patients and 85 age- and sex-matched healthy subjects for measurement of immunoreactive ...
| Known for Platelet Activation | Diabetes Mellitus | Vivo Formation | 8 Iso | Vitamin Supplementation |
PURPOSE: To prospectively validate the use of a simplified geriatric assessment (sGA) at diagnosis and to integrate it into a prognostic score for older patients with diffuse large B-cell lymphoma (DLBCL).
METHODS: We conducted the prospective Elderly Project study on patients with DLBCL older than 64 years who underwent our Fondazione Italiana Linfomi original geriatric assessment (oGA) (age, Cumulative Illness Rating Scale for Geriatrics, activities of daily living, and instrumental ...
| Known for Geriatric Assessment | Diffuse Large | Patients Dlbcl | Cell Lymphoma | Multivariate Analysis |
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs.
[ PUBLICATION ]
Autoimmune cytopenias (AICs) affect 5% to 9% of patients with chronic lymphocytic leukemia (CLL). Targeted drugs-ibrutinib, idelalisib, and venetoclax-have a prominent role in the treatment of CLL, but their impact on CLL-associated AICs is largely unknown. In this study, we evaluated the characteristics and outcome of preexisting AICs and described the incidence, quality, and management of treatment-emergent AICs during therapy with targeted drugs in patients with CLL. We collected data ...
| Known for Targeted Drugs | Patients Cll | Venetoclax Therapy | Treated Ibrutinib | Anti Cd20 |
